Francis Heidt, MD
Family Medicine · Simpsonville, SCNPI 1497796999
Payments from drug & device makers
Across 99 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$290
- Exact Sciences$273
- Novo Nordisk$222
- Pfizer$159
- Lilly USA, LLC$101
- AbbVie$98
- plus $623 from 20 others
What the payments were for
- Food & beverage$1,765100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $290 |
| Exact Sciences | 6 | $273 |
| Novo Nordisk | 14 | $222 |
| Pfizer | 13 | $159 |
| Lilly USA, LLC | 6 | $101 |
| AbbVie(2 entities) | 6 | $98 |
| Daiichi Sankyo Inc. | 4 | $77 |
| Amgen | 5 | $75 |
| AstraZeneca | 5 | $69 |
| GSK | 3 | $50 |
| Dexcom, Inc. | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Amarin Pharma, Inc. | 2 | $32 |
| Eisai Inc. | 1 | $32 |
| Novartis | 2 | $29 |
| Astellas Pharma US Inc | 2 | $26 |
| Edwards Lifesciences | 1 | $26 |
| Boehringer Ingelheim | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Promius Pharma LLC | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,765 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 142 | $160,668 |
| JardianceEmpagliflozin | 144 | $138,306 |
| OzempicSemaglutide | 68 | $80,565 |
| EliquisApixaban | 70 | $69,391 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $26,660 |
| CreonLipase/Protease/Amylase | 11 | $16,304 |
| XareltoRivaroxaban | 17 | $16,272 |
| TrulicityDulaglutide | 12 | $10,230 |
| Esomeprazole Magnesium | 89 | $7,864 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $7,726 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $7,440 |
| JanuviaSitagliptin Phosphate | 11 | $5,810 |
| Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro | 18 | $4,607 |
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 17 | $2,619 |
| Levothyroxine Sodium | 425 | $2,593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humulin N | $101 | $172,444172 claims |
| Boehringer IngelheimJardiance | $20 | $138,306144 claims |
| Novo NordiskOzempic | $222 | $80,56568 claims |
| PfizerEliquis | $159 | $69,39170 claims |
| GSKTrelegy Ellipta | $50 | $26,66034 claims |
| AbbVieCreon, Synthroid | $98 | $18,84545 claims |
| AstraZenecaSymbicort | $69 | $7,72621 claims |
| MerckJanuvia | $11 | $5,81011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Simpsonville
- Robert BrokerSimpsonville$702K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.